BioMarin Pharmaceutical Inc.: UBS cuts target price to $88 from $114
BMRN•UBS cut its target price for BioMarin Pharmaceutical Inc. to $88 from $114.
Related News
WEC Energy Group declares quarterly dividend of 95.25 cents per share
WEC•
GEN Restaurant Group signs deal to sell 47 restaurants to Chubby Group for up to $100 million
GENK•
Westamerica Q3 2026 diluted EPS rises 9% year over year to $1.22
WABC•
Comstock participates in LD Micro 20th Annual Main Event
CHCI•
Bank of America says credit card delinquency rate was 1.37% at September end
BAC•